$5.71-0.28 (-4.75%)
Teladoc Health, Inc.
Teladoc Health, Inc. in the Healthcare sector is trading at $5.71 with a market capitalization of $1.2B. Wall Street consensus targets $7.59 (17 analysts), implying a +32.8% move over the next 12 months. The stock is currently 42% below its 52-week high of $9.89, remaining 12.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $606.93Mβ | $613.85Mβ | $642.27Mβ | $626.44Mβ | $631.90M |
| Gross Profit | $416.09M | $416.32Mβ | $445.22Mβ | $439.26Mβ | $441.36M |
| Operating Income | -$34.50Mβ | -$48.73Mβ | -$26.97Mβ | -$35.46Mβ | -$46.03M |
| Net Income | -$38.91Mβ | -$63.84Mβ | -$25.14Mβ | -$49.51Mβ | -$32.66M |
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical se...